Author:
Corazzelli Gaetano,Capobianco Gaetana,Arcamone Manuela,Ballerini Pier Ferruccio,Iannitto Emilio,Russo Filippo,Frigeri Ferdinando,Becchimanzi Cristina,Marcacci Gianpaolo,De Chiara Annarosaria,Pinto Antonio
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference45 articles.
1. Seyfarth B, Josting A, Dreyling M, Schmitz N (2006) Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease. Br J Haematol 133(1):3–18
2. Schulz H, Bohlius JF, Trelle S, Skoetz N, Reiser M, Kober T et al (2007) Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis. J Natl Cancer Inst 99(9):706–714
3. Moskowitz CH, Bertino JR, Glassman JR, Hedrick EE, Hunte S, Coady-Lyons N et al (1999) Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin’s lymphoma. J Clin Oncol 17(12):3776–3785
4. Zinzani PL, Tani M, Molinari AL, Stefoni V, Zuffa E, Alinari L et al (2002) Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients. Haematologica 87(8):816–821
5. Rodriguez-Monge EJ, Cabanillas F (1997) Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience. Hematol Oncol Clin North Am 11(5):937–947
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献